| Literature DB >> 31715370 |
Wei-Ling Pu1, Meng-Ying Zhang2, Ru-Yu Bai2, Li-Kang Sun3, Wen-Hua Li4, Ying-Li Yu1, Yue Zhang1, Lei Song1, Zhao-Xin Wang1, Yan-Fei Peng5, Hong Shi1, Kun Zhou6, Tian-Xiang Li7.
Abstract
Rhodiola rosea L., a worldwide botanical adaptogen, has been confirmed to possess protective effects of inflammatory injury for many diseases, including cardiovascular diseases, neurodegenerative diseases, diabetes, sepsis, and cancer. This paper is to review the recent clinical and experimental researches about the anti-inflammatory effects and the related mechanisms of Rhodiola rosea L. extracts, preparations, and the active compounds. From the collected information reviewed, this paper will provide the theoretical basis for its clinical application, and provide the evidences or guidance for future studies and medicinal exploitations of Rhodiola rosea L.Entities:
Keywords: Anti-Inflammation; Rhodiola rosea L.; Salidroside; Sofren injection
Mesh:
Substances:
Year: 2019 PMID: 31715370 DOI: 10.1016/j.biopha.2019.109552
Source DB: PubMed Journal: Biomed Pharmacother ISSN: 0753-3322 Impact factor: 6.529